NCT05917964
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Lymphoma, Mantle-Cell
Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.
889 public trials
111 recruiting studies
Lymphoma, Mantle-Cell trial results
NCT00004197
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT00007852
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT00101101
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT01484093
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States
Completed
A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111)
NCT03314922
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Aichi Cancer Center Hospital Aichi, Japan
- National Hospital Organization Kyushu Cancer Center Fukuoka, Japan
- Cancer Institute Hospital of Jfcr Kōtoku, Japan
- Nagoya City University Hospital Nagoya, Japan
NCT03010358
- Conditions
- Anemia, B-Cell Prolymphocytic Leukemia, Chronic Disease, +36 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT00443976
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
- Locations
-
- BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
- Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada
NCT00377052
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- QEII Health Sciences Center Halifax, Nova Scotia, Canada
Completed
A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma
NCT01652144
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- QEII Health Sciences Centre Halifax, Nova Scotia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
- Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada